Delivery Order SPE2DB22D1017-SPE2DB24FF3VB
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,017.97, is a delivery order for the pharmaceutical product Eliquis 5 mg tablet 60s. The contract has an ultimate completion date of October 17, 2023 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $8,091.91 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Eliquis 5 mg tablet. The contract has an ultimate completion date of January 27, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $15,007.34 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of November 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $18,654.74. The contract is for the supply of Eliquis 5 mg tablets for the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of April 3, 2024 and is a firm-fixed-price arrangement. The contract was awarded on April 2, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The $3,325.53 firm-fixed-price delivery order, awarded on February 28, 2024, has an ultimate completion date of February 29, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Firm Fixed Price Delivery Order with a ceiling value of $37,865.86 and a completion date of February 27, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,877.40 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 18, 2023. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,065.25 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablet prescription medication. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $7,665.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with an ultimate completion date of October 30, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award, valued at $11,961.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 5 mg tablets and is designated as a Firm Fixed Price Delivery Order. The award has a period of performance through February 28, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3VBDelivery Order
This contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including the medication Eliquis 5 mg tablets. The contract, valued at $30,322.52, is a firm fixed-price delivery order with a completion date of March 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00, respectively, for the procurement of a comprehensive range of pharmaceutical products and medical supplies. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 3/6/24 |